These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


228 related items for PubMed ID: 2171911

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Predominance of stimulatory effects of interleukin-1 beta on isolated human pancreatic islets.
    Eizirik DL, Welsh N, Hellerström C.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):399-403. PubMed ID: 8432782
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
    Sandler S, Bendtzen K, Borg LA, Eizirik DL, Strandell E, Welsh N.
    Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-1 beta increases the biosynthesis of the heat shock protein hsp70 and selectively decreases the biosynthesis of five proteins in rat pancreatic islets.
    Welsh N, Welsh M, Lindquist S, Eizirik DL, Bendtzen K, Sandler S.
    Autoimmunity; 1991 Mar; 9(1):33-40. PubMed ID: 1669845
    [Abstract] [Full Text] [Related]

  • 10. Liposomal delivery of purified heat shock protein hsp70 into rat pancreatic islets as protection against interleukin 1 beta-induced impaired beta-cell function.
    Margulis BA, Sandler S, Eizirik DL, Welsh N, Welsh M.
    Diabetes; 1991 Nov; 40(11):1418-22. PubMed ID: 1936603
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of interleukin-12 in vitro on pancreatic islets isolated from normal rodents and from non-obese diabetic mice.
    Sternesjö J, Sandler S.
    J Endocrinol; 1998 Jul; 158(1):69-75. PubMed ID: 9713328
    [Abstract] [Full Text] [Related]

  • 17. Metabolism and beta-cell function of rat pancreatic islets exposed to human interleukin-1 beta in the presence of a high glucose concentration.
    Sandler S, Bendtzen K, Eizirik DL, Strandell E, Welsh M, Welsh N.
    Immunol Lett; 1990 Dec; 26(3):245-51. PubMed ID: 2086453
    [Abstract] [Full Text] [Related]

  • 18. Lack of long-term beta-cell glucotoxicity in vitro in pancreatic islets isolated from two mouse strains (C57BL/6J; C57BL/KsJ) with different sensitivities of the beta-cells to hyperglycaemia in vivo.
    Svensson C, Sandler S, Hellerström C.
    J Endocrinol; 1993 Feb; 136(2):289-96. PubMed ID: 8459194
    [Abstract] [Full Text] [Related]

  • 19. Preferential reduction of insulin production in mouse pancreatic islets maintained in culture after streptozotocin exposure.
    Eizirik DL, Sandler S, Welsh N, Hellerström C.
    Endocrinology; 1988 Apr; 122(4):1242-9. PubMed ID: 2450014
    [Abstract] [Full Text] [Related]

  • 20. Decreased cell replication and polyamine content in insulin-producing cells after exposure to human interleukin 1 beta.
    Sandler S, Bendtzen K, Eizirik DL, Sjöholm A, Welsh N.
    Immunol Lett; 1989 Oct; 22(4):267-72. PubMed ID: 2697686
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.